Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 57
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07499700 | A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis | ||
| NCT06044350 | A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders | ||
| NCT04146285 | A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders | ||
| NCT04152759 | Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects | ||
| NCT04151329 | A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor | ||
| NCT05767060 | BAT7104 Injection in Patients With Advanced Malignant Tumors. | ||
| NCT03830203 | Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate | ||
| NCT06111196 | Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects | ||
| NCT05200013 | BAT7104 in Patients With Advanced Solid Tumours | ||
| NCT03884517 | Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer | ||
| NCT05620017 | Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection | ||
| NCT05518695 | Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects | ||
| NCT05155722 | Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors | ||
| NCT05576454 | Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects | ||
| NCT04432766 | A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients | ||
| NCT03030430 | Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects | ||
| NCT04772105 | Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edema | ||
| NCT04185649 | The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer | ||
| NCT07180862 | A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants | ||
| NCT06376136 | A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors | ||
| NCT05116709 | Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors | ||
| NCT05968508 | A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects | ||
| NCT06321068 | BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer | ||
| NCT05109650 | Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients | ||
| NCT05378737 | Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection | ||
| NCT04189211 | A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients | ||
| NCT07515079 | Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema | ||
| NCT03606876 | Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects | ||
| NCT04151212 | A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration | ||
| NCT05377944 | Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients | ||
| NCT04711343 | Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects | ||
| NCT06341114 | A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors | ||
| NCT05180526 | Assessment of Safety , Clinical Efficacy With QLETLI in Non-infectious Uveitis (UV) | ||
| NCT05332730 | A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi® | ||
| NCT06280196 | A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC | ||
| NCT04371185 | Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects | ||
| NCT05414136 | Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 | ||
| NCT06139536 | Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients | ||
| NCT05865574 | A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection | ||
| NCT05046431 | Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis | ||
| NCT05879627 | To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors | ||
| NCT04152148 | A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients | ||
| NCT04135508 | A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira | ||
| NCT05073484 | Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients | ||
| NCT05141994 | Clinical Study on the Efficacy and Safety of BAT5906 Injection | ||
| NCT04728360 | Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis | ||
| NCT05105971 | Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China | ||
| NCT06123884 | BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer | ||
| NCT05439629 | Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration | ||
| NCT06094179 | Evaluate the Safety, Tolerability of BAT6026 |
